Category:Casirivimab/imdevimab

**casirivimab/imdevimab**
	experimental anti-COVID-19 drug developed by Regeneron
	Upload media
	Wikipedia
Instance of	experimental drug; combination drug;
Has part(s)	casirivimab; imdevimab;
Developer	Regeneron Pharmaceuticals;
Inception	2020;
Authority file
	Q99328880;
	Reasonator; Scholia; Wikidocumentaries; PetScan; statistics; WikiMap; Locator tool; KML file; Search depicted;

English: casirivimab/imdevimab: A combination drug of two monoclonal antibodies, casirivimab and imdevimab, used to treat COVID-19

Media in category "Casirivimab/imdevimab"

This category contains only the following file.